Thomas Widman - Actelion Ltd Insider

ALIOF -- USA Stock  

USD 278.50  0.00  0.00%

  Founder
Mr. Thomas Widman is CoFounder at Actelion Ltd. He is a cardiologist educated at Universitat Heidelberg and Paris in Medicine and Computer Science with further training at the University Hospital in Geneva. He later spent seven years at the University of California, San Diego, as Assistant Professor of Medicine and Cardiovascular Associate. During his nine years at F. HoffmannLa Roche, he was responsible for the worldwide clinical development of the company cardiovascular portfolio. He was chairman of F. HoffmannLa Roche cardiovascular strategy team and led an international cardiovascular development team of over 60 people in Europe and the United States. In 1996, he founded Hesperion. Due to his continuing interest in strategic RD and other management topics, he has also attended business courses at INSEAD. As founding member of the Company, he was the Company first Chief Executive Officer and then held the position of Vice Chairman of the Board until spring 2003. He continues to work in close association with the Actelion senior management.
        
41 61 565 65 65  http://www.actelion.com

Management Efficiency

The company has return on total asset (ROA) of 23.87 % which means that it generated profit of $23.87 on every $100 spent on asset. This is very large. Similarly, it shows return on equity (ROE) of 47.08 % meaning that it generated $47.08 on every $100 dollars invested by stockholders.

Entity Summary

Actelion Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. Actelion Ltd (ALIOF) is traded on OTC Market in USA. It is located in Allschwil, and employs 2,500 people.

Actelion Ltd Leadership Team

Thomas Widman, Co-Founder
Christian Albrich, Member of the Management Board, Senior Vice President Head Global Human Resources
Walter Fischli, Senior Vice President Academia Relations
Robert Bertolini, Member of the Board of Directors
Carl Feldbaum, Member of the Board of Directors
Andre Muller, Member of the Management Board, CFO, Executive Vice President
John Greisch, Director
Rudi Frank, Senior Vice President Head Global Quality Management, Member of the Extended Executive Committee
Marian Borovsky, Sr. VP, Group General Counsel and Corporate Secretary
Werner Henrich, Member of the Board of Directors
Nicholas Franco, Member of the Management Board, Executive Vice President Chief Business Development Officer
Martine Clozel, Founder, Chief Scientific Officer, Head of Drug Discovery Pharmacology and Preclinical Devel. and Sr. VP
Juhani Anttila, Member of the Board of Directors
JeanPierre Garnier, Chairman of the Board of Directors
David Stout, Member of the Board of Directors
JeanPaul Clozel, CEO, Member of the Executive Committee, Delegate to the Board of Directors
Guy Braunstein, Member of the Management Board, Executive Vice President Head of Clinical Development
Andrew Weiss, Head of Investor Relations and Corporate Communications and Sr. VP
Herna Verhagen, Member of the Board of Directors
Michael Jacobi, Member of the Board of Directors
Jean Malo, Member of the Board of Directors
Otto Schwarz, COO and Executive VP
Roland Haefeli, Member of the Management Board, Senior Vice President Head of Investor Relations & Public Affairs
Thomas Weller, Vice President Co-Head of Drug Discovery
Peter Gruss, Member of the Board of Directors

Stock Performance Indicators

Current Sentiment - ALIOF

Actelion Ltd Investor Sentiment

Most of Macroaxis users are presently bullish on Actelion Ltd. What is your sentiment towards investing in Actelion Ltd? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Actelion Ltd Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Actelion Ltd and Alamos Gold. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Search macroaxis.com